Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.305 USD | +3.98% | -5.07% | -12.67% |
08/05 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.67% | 113M | |
+4.34% | 111B | |
+11.46% | 105B | |
-12.42% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.04% | 16.96B | |
+2.68% | 13.7B | |
+37.12% | 12.45B |
- Stock Market
- Equities
- IMUX Stock
- News Immunic, Inc.
- Immunic Says Early-Stage Trial Shows 'Positive Effects' of Celiac Disease Drug Over Placebo